Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
CD26 (Dipeptidyl peptidase 4) (DPP4) inhibitors exert their beneficial effect by preventing the inactivation of gut-derived hormones that play a pivotal role in glycemic regulation. More recently, food components have been suggested as sources of DPP-IV inhibitors with the potential to help manage blood glucose levels.
There are multiple FDA‑approved and EMA‑approved CD26 (Dipeptidyl peptidase 4) (DPP4) inhibitors for treatment of Type 2 Diabetes (T2D), marketed as the “gliptin” class.
see also:
Alogliptin & Type 2 Diabetes (T2D)
[Incretins & Type 2 diabetes (T2D)](brain…